Skip to main content

Reviews
Version 1.0 Accessories & Support
Invest in Fisher Wallace until Feb. 20th

IMPORTANT: Proper Battery Placement

Sign up...

Learn more about our groundbreaking technology.

By submitting your email address you confirm you are over 21 and agree to the Fisher Wallace Privacy Policy.

Resources
Accessories

Privacy
We Do Not Sell Customers' Personal Information
Annual Report
Privacy Policy
Terms of Service

About
Reviews
FAQ
Treatment instructions

For Version 1.0 Customers
Accessories

Contact Us
Fisher Wallace Laboratories, Inc.
630 Flushing Avenue
Suite 104
Brooklyn, NY 11206

Phone: 800.692.4380
Fax (rx): 800.657.7362
Email: info@fisherwallace.com

Copyright © 2024 Fisher Wallace

___________________________________

Explanation of Perks, Disclaimers, and Broker-Dealer Information

Perk Eligibility

Only investors who have not previously qualified to receive an OAK® coupon in a prior offering shall qualify to receive an OAK® coupon for a total investment amount of at least $1,995.38 ($2,065.22 with the 3.5% Investor Processing Fee) in this Offering. Only one OAK® coupon will be granted per investor, regardless of how many investments an investor makes in this Offering. (The coupon relates to the Company’s Version 2 device, which remains in development).

Perks are based on both timing and investment amount as follows:

Time of the Investment following Campaign Launch
Investment Amount
Perk

Days 1–7
$100.89 – $1,984.17
135% Bonus Shares

Days 1–7
$1,995.38 – $4,999.66
175% Bonus Shares + OAK® Coupon

Days 1–7
$5,010.87 – $9,999.32
195% Bonus Shares + OAK® Coupon

Days 1–7
$10,010.53 and above
215% Bonus Shares + OAK® Coupon

Days 8–21
$100.89
No perks

Days 8–21
$112.10 – $1,984.17
125% Bonus Shares

Days 8–21
$1,995.38 – $4,999.66
165% Bonus Shares + OAK® Coupon

Days 8–21
$5,010.87 – $9,999.32
185% Bonus Shares + OAK® Coupon

Days 8–21
$10,010.53 and above
200% Bonus Shares + OAK® Coupon

Perks will be calculated for each investor based on the total investment amount. If an investor invests multiple times in this Offering, the combined amount of signed and completed investments will determine what perks the investor receives. Perks will be calculated and assigned to investors after this Offering is completed. See Footnote 3 below for more information regarding the qualification to receive an OAK® coupon.

We are completing the proof of design (prototyping) phase for OAK® (Version 2 Device) and are seeking FDA clearance required for commercial distribution, and expect to commence manufacturing and distribute investigational devices for usability testing, confirmatory testing, and pilot studies in 2025 and 2026, prior to commercially distributing the device under regulatory approval; there may be design and production delays which delay manufacturing or distribution. In addition, we may not successfully complete the design and manufacturing or obtain necessary FDA clearance or approvals for the product, in which case the device may never be delivered. We therefore assign no value to this coupon.

Only investors that have not previously qualified to receive an OAK® coupon in a prior offering shall qualify to receive an OAK® coupon for a total investment amount of at least $1,995.38 ($2,065.22 with the 3.5% Investor Processing Fee) in this Offering. Only one OAK® coupon will be granted per investor, regardless of how many investments an investor makes in this Offering.

Days 1–7 include the day this Offering is launched (the “Launch Date”) through 11:59:59 pm Eastern Standard Time (“EST”) (03:59:59 am Coordinated Universal Time (“UTC”) on the 7th day following the Launch Date (February 6, 2026)). Days 8–21 commence at 12:00 am EST (04:00 am UTC on the 8th day following the Launch Date (February 7, 2026)), and end at 11:59:59 pm EST (03:59:59 am UTC) on the 21st day following the Launch Date (February 20, 2026) (the “Offering Deadline”).

The Maximum Investment permitted for a single investor is $129,656.26 (including the Investor Processing Fee).

No Guarantee of FDA Clearance or Manufacturing

There is no guarantee that OAK® will be manufactured or that regulatory permission (such as FDA approval or clearance) that may be required to distribute OAK® commercially will be granted. At present, some neuromodulation devices intended for wellness are commercially available without a prescription and are not regulated as medical devices; however, these requirements may change. Regulatory permission to distribute OAK® may not be granted, and if granted, a prescription may be required.

Risks of Investing in Startups

Crowdfunding investments in private placements—and startup investments in particular—are speculative and involve a high degree of risk. Investors who cannot afford to lose their entire investment should not invest in startups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development, and their business model, products, and services may not yet be fully developed, operational, or tested in the public marketplace.

There is no guarantee that the stated valuation and other terms are accurate or in agreement with market or industry valuations. Any past performance described is not indicative of future results. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and liquidity concerns.

Broker-Dealer Information

DealMaker Securities LLC, a registered broker-dealer and member of FINRA and SIPC, located at 30 East 23rd Street, 2nd Floor, New York, NY 10010, is the Intermediary for this Offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA’s BrokerCheck.

DealMaker Securities LLC:

Does not make investment recommendations.

Is not placing or selling these securities on behalf of the Issuer.

Is not soliciting this investment or making any recommendations by collecting, reviewing, and processing investor documentation.

Conducts Anti-Money Laundering, Identity, and Bad Actor Disqualification reviews of the Issuer and confirms it is a registered business in good standing, but does not vet or approve the information provided by the Issuer.

Contact information is provided for investors to make inquiries and requests regarding Regulation CF generally, or the status of such investor’s submitted documentation. DealMaker Securities LLC may direct investors to specific sections of the Offering Circular but does not opine on issuer-related matters.

Forward-Looking Statements

This website, as well as the Offering Circular, Form C, and any documents contained therein (collectively, the “Materials”) contains forward-looking statements and are subject to risks and uncertainties. All statements other than statements of historical fact or relating to present facts or current conditions included in the Materials are forward-looking statements. Forward-looking statements give our current reasonable expectations and projections regarding our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts.

These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “should,” “can have,” “likely,” and other words and terms of similar meaning.

The forward-looking statements contained in the Materials are based on reasonable assumptions made in light of industry experience, historical trends, current conditions, expected future developments, and other factors believed appropriate under the circumstances. These statements are not guarantees of performance or results, and actual outcomes may differ materially.

Investors are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements are accurate only as of the date of the Materials. Except as required by law, no obligation is undertaken to update or revise any forward-looking statements.

Past performance is not indicative of future results. Investment is speculative, illiquid, and high risk. Read the Offering Circular for more information.